Tetsuro Kubota
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 1%
- Surgery top 1%
- Molecular Biology top 5%
- Gastroenterology top 0.2%
- Co-authors
- Masaki KitajimaKoichiro KumaiYoshihide OtaniMasahiko WatanabeToshiharu FurukawaRobert M. HoffmanYoshiro SaikawaKyuya Ishibiki
- Topics
- Gastric Cancer Management and Outcomes (89 papers)Colorectal Cancer Treatments and Studies (56 papers)Gastrointestinal Tumor Research and Treatment (36 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryCancer Research
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tetsuro Kubota
292 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 133
- Pulmonary and Respiratory Medicine 2.7k
- Oncology 2.5k
- Surgery 1.9k
- Molecular Biology 1.6k
- Gastroenterology 1.6k
Countries citing papers authored by Tetsuro Kubota
This map shows the geographic impact of Tetsuro Kubota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuro Kubota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuro Kubota more than expected).
Fields of papers citing papers by Tetsuro Kubota
This network shows the impact of papers produced by Tetsuro Kubota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuro Kubota. The network helps show where Tetsuro Kubota may publish in the future.
Co-authorship network of co-authors of Tetsuro Kubota
This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuro Kubota. A scholar is included among the top collaborators of Tetsuro Kubota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuro Kubota. Tetsuro Kubota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Heat shock protein 27 is involved in acquisition of 5-FU resistance in human colon cancer | 1 |
| 2 | 15 | |
| 3 | Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo. | 13 |
| 4 | The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. | 45 |
| 5 | 44 | |
| 6 | 52 | |
| 7 | 5 | |
| 8 | 20 | |
| 9 | 15 | |
| 10 | Pirarubicin might partly circumvent the P-glycoprotein-mediated drug resistance of human breast cancer tissues. | 8 |
| 11 | 2 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 31 | |
| 15 | [High clinical predictability of histoculture drug response assay (HDRA) for drug-sensitivity of cancer of the digestive organs]. | 3 |
| 16 | 23 | |
| 17 | 3 | |
| 18 | 0 | |
| 19 | 4 | |
| 20 | 7 |
About Tetsuro Kubota
Tetsuro Kubota is a scholar working on Gastroenterology, Oncology and Toxicology, having authored 298 papers that have together received 6.7k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (89 papers), Colorectal Cancer Treatments and Studies (56 papers) and Gastrointestinal Tumor Research and Treatment (36 papers). The work is most often cited by research in Gastroenterology (1.6k citations), Biotechnology (865 citations) and Oncology (2.5k citations). Tetsuro Kubota has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masaki Kitajima, Koichiro Kumai, Yoshihide Otani, Masahiko Watanabe, Toshiharu Furukawa, Robert M. Hoffman, Yoshiro Saikawa, Kyuya Ishibiki, Yuko Kitagawa and Masaki Kitajima. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.